News & Insights
10/10/2026Trulive Completes New Round of Over 100 Million Yuan Series C Financing, Continuing to Strengthen Platform Layout in Cardiovascular Intervention
Trulive officially announced the completion of its Series C financing of hundreds of millions of yuan, jointly invested by Oriental Fortune Capital, Guoyuan Equity, Xiamen Industrial Investment/Venture Capital, and other institutions.
Read Full Article
08/28/2026World First Post-Commercialization Implant! Professor Wang Yan's Team from Xiamen Cardiovascular Hospital Performs the First Post-Launch T-TEER with NeoBlazar®, Successfully Treating an 86-Year-Old Patient with Severe Tricuspid Regurgitation
Recently, the team led by Professor Wang Yan from the Cardiovascular Hospital of Xiamen University overcame the challenges of this complex elderly case and performed the first post-launch transcatheter tricuspid edge-to-edge repair (T-TEER) using the NeoBlazar® tricuspid clip system.
Read Full Article
07/22/2026Trulive Medical Launches NeoBlazar® Transcatheter Edge-to-Edge Repair System, Marking the New Domestic Era for Tricuspid Interventional Therapy
Recently, Jiangsu Trulive Medtech Co., Ltd. announced the official NMPA approval for its self-developed NeoBlazar® Transcatheter Tricuspid Clip System (Registration No.: NMPA 20263131494).
Read Full Article
05/29/2026New Milestone in Global Footprint! Xiamen Heart Center Supports Domestic Mitral Clip System's Successful Entry into Argentina
Recently, the NeoNova® transcatheter mitral clip system, independently developed in China, has accelerated its overseas clinical deployment with support from the Cardiovascular Hospital of Xiamen University.
Read Full Article
05/22/2026Double List Honors! Trulive Medical Named to Future Healthcare 100 List Again, Dual Rankings Demonstrate Solid Innovation Capabilities
Recently, the 2026 Future Healthcare & Pharmaceutical 100 Summit, co-hosted by VB Data together with 142 innovative medical and pharmaceutical enterprises, investment institutions, industrial parks and medical institutions, grandly opened in Shanghai.
Read Full Article
05/18/2026Chinese Valves for the World | Xiamen Heart Center Team Supports Domestic Self-Developed Mitral Clip in First Batch Overseas Clinical Procedures in Chile
Recently, the NeoNova® transcatheter mitral clip system, independently developed in China, successfully completed its first two overseas clinical cases at the Hospital del Tórax Instituto Nacional del Tórax (National Thoracic Institute of Chile).
Read Full Article
03/26/2026Trulive Medical's Self-Developed PAFLASH® Pulmonary Thrombus Removal System Obtains NMPA Approval for Market Launch
On March 26, 2026, Trulive Medical's self-developed PAFLASH® Pulmonary Thrombus Removal System has recently obtained approval from the National Medical Products Administration (NMPA) (Registration No.: NMPA 20263030612) and been officially launched in the Chinese market.
Read Full Article
03/09/2026An International Milestone! Joint Efforts by Hong Kong and Xiamen Experts Deliver Two Consecutive Complex Transcatheter Edge-to-Edge Repair (TEER) Procedures in Hong Kong
Recently, amazing clinical results were achieved in the operating room of Canossa Hospital (Hong Kong). A joint team led by Professor Victor Lin (Lin Yixian) and Professor Wong Man Ho (Huang Wenhao) from Canossa Hospital (Hong Kong), together with Professor Chen Xiang under the leadership of Professor Wang Yan, Director of the Cardiovascular Hospital Affiliated to Xiamen University, successfully performed two consecutive complex transcatheter edge-to-edge repair (TEER) procedures in Hong Kong using NeoNova®, the independently developed transcatheter edge-to-edge repair system by Trulive Medical.
Read Full Article- 02/15/2026
Another Milestone! Trulive's TruGamma® Transcatheter Tricuspid Valve Replacement System Granted NMPA Special Review for Innovative Medical Devices
TruGamma® Transcatheter Tricuspid Valve Replacement System, independently developed by Jiangsu Trulive Medtech Co., Ltd. ("Trulive Medical"), has officially passed the Special Review for Innovative Medical Devices administered by the National Medical Products Administration (NMPA).
Read Full Article